Dexmedetomidine, a novel alpha 2-adrenergic agonist for short-term sedation in the intensive care unit.
Le
T
T
Hartford Hospital, Hartford, USA.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D020927:Dexmedetomidine / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007362:Intensive Care Units
D000317:Adrenergic alpha-Antagonists; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine